Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment;Vitamina E como agente protector de hemolisis en pacientes de lepra tratados con dapsona

Medicina

Volumn 57, Issue 2, 1997, Pages 150-154

  Lardo', Marta M ^a   Diaz, Norma B ^a,c   Artaza, Jorge Romero ^a   Carbia, Claudio D ^a   Nazer, Raquel ^b   Valdez, Raul ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DAPSONE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ADULT; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE MEMBRANE; FEMALE; HEMOLYSIS; HUMAN; LEPROSY; MALE; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS;

EID: 0030955656     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kelly JW, Scott J, Sandland M. Vitamin E and Dapsone induced hemolysis. Arch Dermatol 1984; 120: 1582-1684.
2. Feher J, Csomos G, Vereckei A. Free Radical Reactions in Medicine. Berlin: Springer-Verlag, 1987.
3. Rosen JP, Cage J, McGee W, Beutler E. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med 1971; 75: 83-6.
4. Erstad B, et al. Dapsone induced metahemoglobinemia and hemolytic anemia, Clin Pharm 1992; 11: 800.
5. Beutler E, Maroose R, Kramer L, Gelbart T, Forman L. Gamma-glutamylcysteine synthetase deficiency and hemolytic anemia. Blood 1990; 75: 271-3.
6. Beutler E. Hemolytic anemia in disorders of red cell metabolism. New York: Plenum Press, 1978.
7. Beutler E. The genetics of glucose-6- phosphate dehydrogenase deficiency. Sem Hematol 1990; 27; 137-64.
8. Lukens J, Lee R, Bithell T, et al. Wintrobe-Hematología Clínica. Novena Edición, Buenos Aieres: El Ateneo, 1994.
9. Spielberg SP, Boxer A, Corash LM, Schulman JD. Improved erythrocyte survival with high.dose vitamin E in chronic hemolyzing G-6PD and Glutathione Syntetase deficiencies. Ann Inter Med 1979; 90: 53-4.
10. Rasbrigde MR, Scott GL. The haemolytic action of dapsone changes in the red cell membrane. Br J Haem 1973; 24: 183-93.
11. Brewer G, Tarlov A, Alving A. The metahemoglobin reduction test for primaquine type sensitivity of erythrocytes. A simplified procedure for detecting specific hypersusceptibility drug hemolyisis. JAMA 1986; 180: 386.
12. Yeung CY, Edin CP, Glasg AC, et al. Brief fluorescent spot test for screening erythrocyte glucose-6 phosphate dehydrogenase deficiency in newborn babies. Brief clinical and laboratory observations. J Pediatr 1970; 76: 931-4.
13. Evelyn E, Malloy T. Microdetermination of oxyhemo-globin, metahemoglobin and sulfahemoglobin in a single sample of blood. J Biol Chem, 1938; 126: 655.
14. Beutler E, Dem RJ, Alving AS. An in vitro test for sensitivity of erythrocytes to primaquine. J Labor Clin Med 1955; 45: 40.
15. Lynnel M, Schwab ML, Lewis AE. An improved stain for Heinz bodies Am J Clin Phat, 1968; 51: 673-5.
16. Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, Valentine N. International Committee for Standardization in Haematology: Recommended Screening test for Glucose 6-Phosphate Dehydrogenase (G-6PD) Br J Haemat 1979; 43: 465-8.
17. Dal Y, Lessin L, Drug Associated «Bite Cell» Hemolytic Anemia. Am J Med 1992; 92: 243-8.
18. Prussik R, Mahmoud AM. The protective effect of Vitamin E on the hemolysis associated with dapsone treatment in patients with Dermatitis Herpetiforrnis. Arch Dermatol 1992; 128: 210-3.
19. Feher J, Csomos G, Vereckei A. Free Radical Reactions in Medicine, Berlin: Springer-Verlag, 1987.
20. Samuel T. Effect of tumor necrosis factor on the generation of chlorinated oxidants by adherent human neutrophils. J Leuk Biol 1991; 50: 131-9.
21. Roberts HJ. Perspective of Vitamin E as therapy. JAMA, 1981; 246: 129.